MARINOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Marinol, and when can generic versions of Marinol launch?
Marinol is a drug marketed by Alkem Labs Ltd and is included in one NDA.
The generic ingredient in MARINOL is dronabinol. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dronabinol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Marinol
A generic version of MARINOL was approved as dronabinol by ASCENT PHARMS INC on February 7th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MARINOL?
- What are the global sales for MARINOL?
- What is Average Wholesale Price for MARINOL?
Summary for MARINOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 38 |
| Clinical Trials: | 57 |
| Patent Applications: | 3,742 |
| Drug Prices: | Drug price information for MARINOL |
| What excipients (inactive ingredients) are in MARINOL? | MARINOL excipients list |
| DailyMed Link: | MARINOL at DailyMed |
Recent Clinical Trials for MARINOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ralph H. Johnson VA Medical Center | Phase 2 |
| JHSPH Center for Clinical Trials | Phase 2 |
| Yale University | Phase 1 |
Pharmacology for MARINOL
| Drug Class | Cannabinoid |
US Patents and Regulatory Information for MARINOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alkem Labs Ltd | MARINOL | dronabinol | CAPSULE;ORAL | 018651-001 | May 31, 1985 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alkem Labs Ltd | MARINOL | dronabinol | CAPSULE;ORAL | 018651-002 | May 31, 1985 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alkem Labs Ltd | MARINOL | dronabinol | CAPSULE;ORAL | 018651-003 | May 31, 1985 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MARINOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Alkem Labs Ltd | MARINOL | dronabinol | CAPSULE;ORAL | 018651-001 | May 31, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| Alkem Labs Ltd | MARINOL | dronabinol | CAPSULE;ORAL | 018651-003 | May 31, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| Alkem Labs Ltd | MARINOL | dronabinol | CAPSULE;ORAL | 018651-002 | May 31, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
